NewAmsterdam Pharma (NAMS) News Today $23.95 -0.52 (-2.13%) Closing price 04:00 PM EasternExtended Trading$23.94 0.00 (-0.02%) As of 05:36 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NAMS Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Louise Frederika Kooij Sells 8,269 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) StockAugust 28 at 8:31 AM | insidertrades.comInsider Selling: NewAmsterdam Pharma (NASDAQ:NAMS) Insider Sells 50,000 Shares of StockAugust 27 at 5:13 PM | marketbeat.comWells Fargo & Company Initiates Coverage on NewAmsterdam Pharma (NASDAQ:NAMS)August 27 at 8:26 AM | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Insider Johannes Jacob Piete Kastelein Sells 50,000 Shares of StockAugust 26 at 4:37 AM | americanbankingnews.comJohannes Jacob Piete Kastelein Sells 50,000 Shares of NewAmsterdam Pharma (NASDAQ:NAMS) StockAugust 26 at 4:02 AM | insidertrades.comNewAmsterdam Pharma (NASDAQ:NAMS) Earns Overweight Rating from Analysts at Wells Fargo & CompanyAugust 26 at 2:05 AM | americanbankingnews.comExpert Outlook: NewAmsterdam Pharma Co Through The Eyes Of 6 AnalystsAugust 25 at 6:06 PM | benzinga.comWells Fargo Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Overweight RecommendationAugust 25 at 6:06 PM | msn.comNewAmsterdam Pharma initiated with an Overweight at Wells FargoAugust 25 at 6:06 PM | msn.comNewAmsterdam Pharma to Participate in Upcoming Medical Meeting and Investor Conferences in SeptemberAugust 25 at 8:00 AM | globenewswire.comWellington Management Group LLP Raises Stock Position in NewAmsterdam Pharma Company N.V. $NAMSAugust 25 at 4:42 AM | marketbeat.comDeutsche Bank AG Boosts Stock Position in NewAmsterdam Pharma Company N.V. $NAMSAugust 25 at 3:29 AM | marketbeat.comAberdeen Group plc Has $7.71 Million Stock Position in NewAmsterdam Pharma Company N.V. $NAMSAugust 23, 2025 | marketbeat.comPiramal Pharma Solutions and NewAmsterdam Pharma Invest in Dedicated Suite to Enhance Oral Solid Dosage Production Capabilities at Piramal's Sellersville, Pennsylvania SiteAugust 21, 2025 | prnewswire.comNewAmsterdam Pharma’s EMA Validation for ObicetrapibAugust 19, 2025 | msn.comNewAmsterdam Announces Acceptance of Marketing Authorization Applications for Review by European Medicine Agency for ObicetrapibAugust 18, 2025 | globenewswire.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director James N. Topper Buys 471 SharesAugust 15, 2025 | marketbeat.comInsider Buying: NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director Purchases 471 Shares of StockAugust 14, 2025 | insidertrades.comAnalysts Issue Forecasts for NAMS FY2026 EarningsAugust 12, 2025 | marketbeat.comBullish: Analysts Just Made A Meaningful Upgrade To Their NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) ForecastsAugust 12, 2025 | finance.yahoo.comLeerink Partnrs Issues Optimistic Outlook for NAMS EarningsAugust 11, 2025 | marketbeat.comWilliam Blair Brokers Increase Earnings Estimates for NAMSAugust 11, 2025 | marketbeat.comScotiabank Keeps Their Buy Rating on NewAmsterdam Pharma Company (NAMS)August 10, 2025 | theglobeandmail.comAnalysts Are Upgrading NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) After Its Latest ResultsAugust 9, 2025 | finance.yahoo.comNewAmsterdam Pharma (NASDAQ:NAMS) Trading 10.1% Higher Following Analyst UpgradeAugust 9, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 9, 2025 | marketbeat.comRoyal Bank Of Canada Issues Positive Forecast for NewAmsterdam Pharma (NASDAQ:NAMS) Stock PriceAugust 8, 2025 | marketbeat.comWhat 5 Analyst Ratings Have To Say About NewAmsterdam Pharma CoAugust 8, 2025 | benzinga.comCenterBook Partners LP Purchases 13,675 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)August 8, 2025 | marketbeat.comNewAmsterdam Pharma Clears Key Benchmark, Hitting 80-Plus RS RatingAugust 7, 2025 | msn.comNewAmsterdam Pharma Second Quarter 2025 Earnings: US$0.15 loss per share (vs US$0.41 loss in 2Q 2024)August 7, 2025 | finance.yahoo.comNewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial ResultsAugust 6, 2025 | globenewswire.comDCF Advisers LLC Acquires 83,100 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)August 4, 2025 | marketbeat.comNewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer's Disease Biomarkers at AAIC 2025July 30, 2025 | globenewswire.comNewAmsterdam Pharma (NAMS) Projected to Post Earnings on WednesdayJuly 30, 2025 | marketbeat.comBryce Point Capital LLC Invests $438,000 in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)July 28, 2025 | marketbeat.comReadystate Asset Management LP Reduces Stock Position in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)July 23, 2025 | marketbeat.comNewAmsterdam Pharma to Present Alzheimer's Biomarker Data from BROADWAY Trial at AAIC 2025July 22, 2025 | globenewswire.comAtle Fund Management AB Cuts Stock Holdings in NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS)July 19, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Shares Sold by Jennison Associates LLCJuly 19, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) COO Sells $1,019,879.36 in StockJuly 18, 2025 | marketbeat.comInsider Selling: NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) COO Sells 51,043 Shares of StockJuly 18, 2025 | marketbeat.comDouglas F. Kling Sells 47,569 Shares of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) StockJuly 18, 2025 | insidertrades.comGoldman Sachs Initiates Coverage of NewAmsterdam Pharma Company N.V. (NAMS) with Neutral RecommendationJuly 17, 2025 | msn.comNewAmsterdam Pharma (NASDAQ:NAMS) Coverage Initiated at The Goldman Sachs GroupJuly 17, 2025 | marketbeat.comJefferies Remains Bullish on NewAmsterdam Pharma (NAMS)July 16, 2025 | msn.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Receives Average Rating of "Buy" from AnalystsJuly 14, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Trading Up 5.7% - Still a Buy?July 9, 2025 | marketbeat.comNewAmsterdam Pharma (NASDAQ:NAMS) Stock Rating Upgraded by Wall Street ZenJuly 5, 2025 | marketbeat.comNewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) Director James N. Topper Purchases 1,260 SharesJune 27, 2025 | insidertrades.com Get NewAmsterdam Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NAMS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NAMS Media Mentions By Week NAMS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NAMS News Sentiment▼0.611.03▲Average Medical News Sentiment NAMS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NAMS Articles This Week▼177▲NAMS Articles Average Week Get the Latest News and Ratings for NAMS and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NewAmsterdam Pharma and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Qiagen News Moderna News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Elanco Animal Health News Blueprint Medicines News Roivant Sciences News Grifols News Legend Biotech News Revolution Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NAMS) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredWhat Are Some Strategies to Help Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Company N.V. Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access